RxDoctor Payments Data

Marco Palmieri, DO

Anesthesiology · Garden City, NYNPI 1649447335

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Boston Scientific at 25.2% of the total. Among anesthesiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,792in general payments, 2019–2025

Across 149 payments — averaging $32.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Medtronic$869
  • Saluda Medical Americas, Inc.$860
  • Relievant Medsystems, Inc.$805
  • Abbott$501
  • Nevro Corp.$281
  • plus $268 from 4 others
$7,106in research payments, 2019–2025

Across 3 payments — averaging $2368.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$7K

What the payments were for

  • Food & beverage$4,792100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,792 in reported general payments places this provider in the 95th percentile of 4,157 anesthesiology providers in New York.

See all anesthesiology providers in New York →

Medicare billing

Part B allowed, 2024
$385,562
Medicare patients
591
Services billed
4,381

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin70$3,199
Gabapentin206$2,270
Celecoxib101$2,013
Tizanidine Hcl40$406
Duloxetine Hcl13$339
Meloxicam117$313
Diclofenac Sodium21$283
Methocarbamol35$237
Methylprednisolone32$196
Cyclobenzaprine Hcl35$173
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$156
Naproxen37$149
Tramadol Hcl65$135
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$102
Diazepam16$9

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Garden City

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →